Atlas Trials

Clinical Trial Evaluating the Efficacy and Safety of Favipiravir in Moderate to Severe COVID-19 Patients

Clinical trial NCT04529499 · TERMINATED

Trial details

NCT number
NCT04529499
Sponsor
Dr. Reddy's Laboratories Limited
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Covid19
Start date
2020-08-22
Primary completion
2021-01-22
Enrollment
353

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.